Resultado de búsqueda
Hugh Auchincloss, Jr. (pronounced: aa-kuhn-klaas; born March 15, 1949) is an American immunologist and physician serving as the acting director of the National Institute of Allergy and Infectious Diseases since 2023. He previously served as the principal deputy director between 2006 and 2022.
- Hugh Auchincloss III, March 15, 1949 (age 74), New York City, U.S.
- Anthony Fauci
- 3, including Jake
Hugh Dudley Auchincloss Jr. (August 15, 1897 – November 20, 1976) was an American stockbroker and lawyer. He became the second husband of Nina S. Gore, mother of Gore Vidal, and also the second husband of Janet Lee Bouvier, the mother of First Lady Jacqueline Kennedy Onassis (wife of President John F. Kennedy) and Caroline Lee Bouvier . Early life.
11 de feb. de 2023 · Hugh Auchincloss was Anthony Fauci’s longtime deputy. Now he’s taking his job as House Republicans probe the pandemic. By Jim Puzzanghera — Boston Globe. Reprints. Hugh Auchincloss, a...
Recorded February 2022. Jacob Daniel Auchincloss ( / ˈɔːkɪnklɒs / AW-kin-kloss; born January 29, 1988) [1] is an American politician, businessman, and Marine veteran serving as the U.S. representative for Massachusetts's 4th congressional district since 2021. He is a member of the Democratic Party .
24 de sept. de 2023 · Hugh Auchincloss, M.D., serves as NIAID Principal Deputy Director. In this capacity, Dr. Auchincloss is responsible for the following: Providing leadership for all NIAID research planning and implementation activities, including helping to prepare and support a strategic vision for NIAID.
20 de ene. de 2023 · Dr. Hugh Auchincloss has agreed to serve as acting director of the National Institute of Allergy and Infectious Diseases (NIAID). Auchincloss assumed the acting role on Jan. 1. He has served as NIAID’s principal deputy director since joining NIH in 2006.
22 de sept. de 2023 · “The evidence is clear that immune modulation can be beneficial for severely ill COVID-19 patients,” said NIAID Acting Director Hugh Auchincloss, M.D. “Patients with milder cases of COVID-19 are often administered one immune modulator, and a second treatment is added only if the patient becomes severely ill.
